Adam Kittai
Unknown
Best podcasts with Adam Kittai
Ranked by the Snipd community
Feb 18, 2022 • 19min
ASH 2021: highlights in CLL clinical trials
Dr. Jennifer Woyach and Adam Kittai discuss key topics in CLL treatment, including the efficacy of targeted therapies ibrutinib and venetoclax, promising alternative options like pirtobrutinib and MK1026, resistance mechanisms of BTK inhibitors, reverse wovit decay inhibitors MK1026 and ARQ531, promising molecules CDK9 inhibitor VIP152 and BCL2, BCL-XL inhibitor LP118, and the importance of undetectable minimal residual disease in CLL.
